Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Seventure Partners
BioCentury | Dec 13, 2024
Finance
Techbio VC Dimension upsizes for $500M second fund; PE firm takes stake in Andera
In BioCentury’s Venture Report: Fundings for Citryll, Angitia, Tasca, Veradermics and more
BioCentury | Jun 5, 2024
Emerging Company Profile
Tubulis: Enhancing ADC stability via new conjugation methods
German biotech raised series B2 round in March to push two highly stable ADC candidates into the clinic, and discover new payloads
BioCentury | Mar 14, 2024
Finance
Venture Report: Tubulis’ big B round to advance ADCs, Relation adds to seed financing
Plus new rounds for Mission, Asgard and more
BioCentury | Dec 6, 2023
Deals
Dec. 5 Quick Takes: Nearing clinic, Odyssey raises $101M series C
Plus: Genentech PI3K combo meets PFS endpoint in Phase III and more from ImmunoGen, SpringWorks, Eligo, BrainChild, Axcella, Sanofi, Aqemia and IGM
BioCentury | Apr 25, 2023
Deals
April 25 Quick Takes: Final outcome for decades-old Spectrum is Assertio merger
Plus: Arrowhead buoyed by pulmonary data and updates from Novartis, Vedanta and Ventoux
BioCentury | May 11, 2022
Product Development
May 10 Quick Takes: ‘molecular machines’ company MOMA lands $150M series B
Plus GPCR play Domain raises $42M and updates from OncoHost, Eisai, UCB, Idorsia and more
BioCentury | May 4, 2022
Finance
May 3 Quick Takes: Tubulis raises €60M series B for ADC pipeline
Plus Spero scraps commercial plans for tebipenem and updates from Pfizer, Bayer-Orion and more
BioCentury | Mar 8, 2022
Finance
Microbiotica heads to the clinic with Europe’s largest microbiome financing
U.K. biotech raises £50M to advance immuno-oncology, ulcerative colitis programs
BioCentury | Oct 14, 2021
Finance
Abalos adds €32.5M to series A round
Funds enable German biotech to push immuno-virotherapy into clinic within next two years
BioCentury | Oct 14, 2021
Regulation
Oct. 13 Quick Takes: Lilly’s Verzenio approved in early breast cancer
Plus Ardelyx, Takeda, Merck, Berry, Axial
Items per page:
1 - 10 of 79